N-glycan alterations are associated with drug resistance in human hepatocellular carcinoma
<p>Abstract</p> <p>Background</p> <p>Correlations of disease phenotypes with glycosylation changes have been analysed intensively in the tumor biology field. Glycoforms potentially associated with carcinogenesis, tumor progression and cancer metastasis have been identif...
Main Authors: | Nakagawa Takahito, Nakanishi Kazuaki, Yokoo Hideki, Kamiyama Naoya, Hamaguchi Jun, Takahashi Masato, Nakagawa Hiroaki, Kudo Takeaki, Kamiyama Toshiya, Deguchi Kisaburo, Nishimura Shin-Ichiro, Todo Satoru |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2007-05-01
|
Series: | Molecular Cancer |
Online Access: | http://www.molecular-cancer.com/content/6/1/32 |
Similar Items
-
Swainsonine reduces 5-fluorouracil tolerance in the multistage resistance of colorectal cancer cell lines
by: Sato Yuji, et al.
Published: (2007-09-01) -
Analysis of the risk factors for early death due to disease recurrence or progression within 1 year after hepatectomy in patients with hepatocellular carcinoma
by: Kamiyama Toshiya, et al.
Published: (2012-06-01) -
Healthy human serum N-glycan profiling reveals the influence of ethnic variation on the identified cancer-relevant glycan biomarkers.
by: Abrha G Gebrehiwot, et al.
Published: (2018-01-01) -
A long-term survival case of adult undifferentiated embryonal sarcoma of liver
by: Noguchi Keita, et al.
Published: (2012-04-01) -
Adenomatous polyposis coli-binding protein end-binding 1 promotes hepatocellular carcinoma growth and metastasis.
by: Takeshi Aiyama, et al.
Published: (2020-01-01)